IPR2018-01287 - Novartis Pharmaceuticals Corp v. Plexxikon Inc

Details
PATENT NUMBER
9469640 Medical
APPL. NUMBER
15048851
PETITIONER
Novartis Pharmaceuticals Corp
Large Operating Company
PATENT OWNER
Plexxikon Inc
Operating Company
STATUS
Not Instituted - Procedural § 325(d)
FILING DATE
2018-06-18
INSTITUTION DATE
2019-01-16
TERMINATION DATE
2019-01-16
PET. COUNSEL
McDermott Will & Emery LLP
P.O. COUNSEL
Weil, Gotshal & Manges LLP
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Preliminary Response
Institution Decision
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Docket
Paper No.
Date
Party
Type
Name
12018-06-18PetitionerPower of AttorneyPower of Attorney
22018-06-18PetitionerPetitionPETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 9,469,640
32018-06-18PetitionerOtherPETITIONER¿¿¿S MOTION FOR ADMISSION PRO HAC VICE OF THOMAS P. STEINDLER
42018-06-18PetitionerOtherDeclaration of Thomas P. Steindler in Support of Petitioners Motion for Admission Pro Hac Vice
52018-06-18PetitionerOtherof Petitioners Motion for Admission Pro Hac Vice of David Mlaver
62018-06-18PetitionerOtherDeclaration of David Mlaver in Support of Petitioners Motion for Admission Pro Hac Vice
10012018-06-18PetitionerWu et al., U.S. Patent No. 9,469,640
10022018-06-18PetitionerDeclaration of Phil S. Baran, Ph.D.
10032018-06-18PetitionerPhil S. Baran, Ph.D CV
10042018-06-18PetitionerU.S. Application No. 12/669,450
10052018-06-18PetitionerProsecution History, October 4, 2013 Office Action
10062018-06-18PetitionerTara R. Rheault, U.S. Patent No. 7,994,185
10072018-06-18PetitionerProsecution History, June 5, 2014 Notice of Abandonment
10082018-06-18PetitionerProsecution History, April 3, 2015 Office Action
10092018-06-18PetitionerProsecution History, August 3, 2015 Amendment and Reply
10102018-06-18PetitionerProsecution History, September 3, 2015 Office Action
10112018-06-18PetitionerProsecution History, Examiner¿¿¿s Summary of January 15, 2016 Interview
10122018-06-18PetitionerProsecution History, Statement of Substance of Interview
10132018-06-18PetitionerProsecution History, April 18, 2016 Notice of Abandonment
10142018-06-18PetitionerProsecution History, February 19, 2016 Preliminary Amendment
10152018-06-18PetitionerProsecution History, April 18, 2016 Office Action
10162018-06-18PetitionerProsecution History, July 20, 2016 Amendment and Response
10172018-06-18PetitionerProsecution History, September 2, 2016 Notice of Allowance
10182018-06-18PetitionerMartin et al., ¿¿¿Palladium-Catalyzed Suzuki-Miyaura Cross-Coupling Reactions Employing Dialkylbiaryl Phosphine Ligands
10192018-06-18PetitionerD¿¿fert et al., Suzuki-Miyaura Cross-Coupling of Unprotected
10202018-06-18PetitionerKinzel et al., A New Palladium Precatalyst Allows for the Fast Suzuki-Miyaura Coupling
10212018-06-18PetitionerJedin¿¿k et al., The Suzuki¿¿¿Miyaura Cross-Coupling Reaction of Halogenated Aminopyrazoles
10222018-06-18PetitionerElizabeth Tyrrell and Phillip Brookes, The Synthesis and Applications of Heterocyclic Boronic Acids
10232018-06-18PetitionerH¿¿mmerle et al., A guideline for the arylation of positions 4 and 5
10242018-06-18PetitionerCox et al., Protodeboronation of heteroaromatic, vinyl and cyclopropyl boronic acids
10252018-06-18PetitionerSuzuki, Cross-Coupling Reactions of Organoboranes
10262018-06-18PetitionerLi and Gribble, PALLADIUM IN HETEROCYCLIC CHEMISTRY
72018-06-29Potential Patent OwnerPower of AttorneyPatent Owner's Power of Attorney
82018-06-29Potential Patent OwnerMandatory NoticePatent Owner's Mandatory Notices Pursuant to 37 C.F.R. 42.8
92018-07-19BoardNotice of Filing DateNotice of Accord Filing Date
102018-10-18Potential Patent OwnerPreliminary ResponsePatent Owner's Preliminary Response
112018-10-18Potential Patent OwnerOtherMotion for Pro Hac Vice Admission Under 37 C.F.R. 42.10
122018-10-18Potential Patent OwnerPatent Owner's Updated Exhibit List
20012018-10-18Potential Patent OwnerJune 29, 2012 Office action filed in the prosecution of U.S. Application 12/669,450
20022018-10-18Potential Patent OwnerFebruary 19, 2016 Preliminary Amendment filed in the prosecution of U.S. Patent No. 9,469,640
20032018-10-18Potential Patent OwnerJuly 16, 2016 Interview Summary filed in the prosecution of U.S. Patent No. 9,469,640
20042018-10-18Potential Patent OwnerJames Tsai, et al., ¿¿¿Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity¿¿¿, PNAS (2008) 105:8, 3041-3046.
20052018-10-18Potential Patent OwnerJohn C. Stellwagen et al., ¿¿¿Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup¿¿¿, Bioorganic & Medicinal Chemistry Letters 21 (2011) 4436-4440.
20062018-10-18Potential Patent OwnerTara R. Rheault, et al., ¿¿¿Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors¿¿¿, ACS Medicinal Chemistry Letters (2013), 4, 358-362.
20072018-10-18Potential Patent OwnerBio of Anna E. Dwyer
20082018-10-18Potential Patent OwnerDeclaration of Anna E. Dwyer in Support of Motion for Pro Hac Vice Admission Under 37 C.F.R. 42.10
132018-11-19BoardOtherConduct of the Proceeding
142018-11-30BoardOtherOrder Granting Petitioner's Motion for Admission Pro Hac Vice of Thomas P. Steindler
152018-11-30BoardOtherOrder Granting Petitioner's Motion for Admission Pro Hac Vice of David Mlaver
162018-11-30BoardOtherOrder Conditionally Granting Patent Owner's Motion for Admission Pro Hac Vice of Anna E. Dwyer
172019-01-16BoardInstitution DecisionTrial Instituted Document
Grounds Asserted

Not a member? Sign up for free!